On August 27, 2020 Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to transform the pace, risk and cost of oncology drug discovery and development, and identify patients who will benefit from its targeted oncology drug candidates, reported that Panna Sharma, CEO and President, will provide company updates at the following investor events in September (Press release, Lantern Pharma, AUG 27, 2020, View Source [SID1234564131]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The LD Micro 500
Date/Time: September 1, 2020 at 2:40 p.m. ET

MedInvest AI, Big Data & Digital Health Conference
Date/Time: September 9, 2020 at 10:40 a.m. ET

Colliers Institutional Investor Conference
Date/Time: September 10, 2020 at 9:00 a.m. ET to 5:00 p.m. ET (1×1 only; no presentation)

H.C. Wainwright 22nd Annual Global Investor Conference
Date/Time: September 15, 2020 at 4:30 p.m. ET

AI 2020, 13th Annual BioPharm America Conference
Fireside Chat: Using AI to Optimize Drug Selection and Development, hosted by Zacks Investment Research John Vandermosten
Date/Time: September 21, 2020 at 11:45 a.m. ET
All meetings and presentations will be held virtually. Investors and media interested in meeting with Panna Sharma should contact Marek Ciszewski, J.D., at: [email protected] or +1.628.777.3167. Registered conference attendees may also request meetings through the respective conference registration system.